The technology has the potential to be implemented across multiple aspects of the industry.
Timothy Bubb
Advertisement
Articles by Timothy Bubb
Advertisement
Latest Updated Articles
Advertisement
Advertisement
Trending on PharmExec
1
Mark Cuban Pushes for Generic Drug Fee Waivers, as Cost Plus Drugs Eyes US Manufacturing Expansion
2
FDA Appoints Tracy Beth Høeg as Acting Director of CDER
3
FDA Approves Expanded Indication of Jaypirca for Adults with Relapsed or Refractory Chronic Lymphocytic Leukemia or Small Lymphocytic Lymphoma
4
Patients Avoid Care as Healthcare Costs Rise: Report
5
